日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Real-World Modifications of Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Hyperkalemia Initiating Sodium Zirconium Cyclosilicate Therapy: The OPTIMIZE I Study

在开始使用锆硅酸钠治疗的高钾血症患者中,肾素-血管紧张素-醛固酮系统抑制剂的真实世界调整:OPTIMIZE I 研究

Agiro, Abiy; An, Amin; Cook, Erin E; Mu, Fan; Chen, Jingyi; Desai, Pooja; Oluwatosin, Yemmie; Pollack, Charles V Jr

Discontinuation of Renin-Angiotensin-Aldosterone System Inhibitors Secondary to Hyperkalemia Translates into Higher Cardiorenal Outcomes

因高钾血症而停用肾素-血管紧张素-醛固酮系统抑制剂会导致更高的心肾不良事件发生率。

An, Jaejin; Zhou, Hui; Ni, Liang; Harrision, Teresa N; Wei, Rong; Agiro, Abiy; Brahmbhatt, Yasmin Ghanshyam; Oluwatosin, Yemmie; Schilling, Craig G; Sim, John J